Record overview
Status and phase
Status: COMPLETED
Phase: PHASE1, PHASE2
Sponsor: BioMed Valley Discoveries, Inc
Condition: Acute Myelogenous Leukemia, Myelodysplastic Syndrome
NCT02296242
Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.